| Net Cash Provided by (Used in) Operating Activities |
278,992,000 |
USD |
+60.6% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
-243,239,000 |
USD |
-20.1% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
1,152,100,000 |
shares |
-14.8% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
465,916,352 |
shares |
+7.5% |
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
35,753,000 |
USD |
|
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
86,541,000 |
USD |
+51.8% |
Q3 2025 |
Q1 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
26,336,000 |
USD |
-27.6% |
Q3 2025 |
Q1 2026 |
| Additional Paid in Capital |
4,272,510,000 |
USD |
+0.53% |
Q3 2025 |
Q1 2026 |
| Interest Expense |
39,841,000 |
USD |
+6.2% |
Q1 2024 |
Q3 2024 |